Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly Gemcitabine and Docetaxel in Advanced NSCLC with ECOG PS 2
NCT00906061Phase 2Unknown
- Sponsor
- Hospital Universitari Arnau de Vilanova
- Start
- Oct 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in non-small cell lung carcinoma (NSCLC), sponsored by Hospital Universitari Arnau de Vilanova. Status: unknown.
02
Drugs
gemcitabinedocetaxel
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT00906061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906061.